Skip to main content
Erschienen in: Journal of Neurology 8/2021

16.02.2021 | Original Communication

Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage

verfasst von: Junpei Koge, Kanta Tanaka, Takeshi Yoshimoto, Masayuki Shiozawa, Hiroshi Yamagami, Tetsu Satow, Jun C. Takahashi, Masafumi Ihara, Masatoshi Koga, Jun-ichi Kira, Kazunori Toyoda

Erschienen in: Journal of Neurology | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Patients with intracranial hemorrhages (ICH) after mechanical thrombectomy (MT) may have a higher risk of early recurrent embolism (ERE) because of delayed initiation of anticoagulants. We assessed the rate of ischemic events in the early period after MT and the association with post-MT ICH.

Methods

Patients who underwent MT in our institute were retrospectively reviewed. ERE was defined as recurrent ischemic stroke and systemic embolism within 14 days after MT. The association between ERE and parenchymal hematoma (PH) was assessed. Multivariable regression analysis and inverse probability of treatment weighting was used to adjust for differences in baseline characteristics between patients with and without PH.

Results

A total of 307 patients (median age, 78 years; female, 47%; median baseline National Institutes of Health Stroke Scale score, 19) were included. ERE was observed in 12 of 307 patients (8 strokes, 4 systemic embolisms; 3.9%). Median time from MT to ERE was 6.5 days (IQR, 3–8 days). PH occurred in 21 patients (6.8%). Median time from MT to initiating oral anticoagulants was longer in patients with PH (8 days) than in those without (3 days) (p < 0.01). In both unweighted and weighted multivariable analysis, PH was significantly associated with an increased risk of ERE (unweighted odds ratio, 10.60; 95% CI, 2.66–42.23; weighted odds ratio, 12.34; 95% CI, 2.49–61.07).

Conclusions

ERE occurred in about 4% of patients after MT. PH after MT was associated with delayed initiation of oral anticoagulants and an increased risk of recurrent ischemic events.

Clinical trial registration

URL: https://​www.​clinicaltrials.​gov. Unique identifier: NCT02251665.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731CrossRef Goyal M, Menon BK, van Zwam WH, Dippel DWJ, Mitchell PJ, Demchuk AM et al (2016) Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet 387:1723–1731CrossRef
2.
Zurück zum Zitat Pirson FAV, van Oostenbrugge RJ, van Zwam WH, Remmers MJM, Dippel DWJ, van Es A et al (2020) Repeated endovascular thrombectomy in patients with acute ischemic stroke: results from a nationwide multicenter database. Stroke 51:526–532CrossRef Pirson FAV, van Oostenbrugge RJ, van Zwam WH, Remmers MJM, Dippel DWJ, van Es A et al (2020) Repeated endovascular thrombectomy in patients with acute ischemic stroke: results from a nationwide multicenter database. Stroke 51:526–532CrossRef
3.
Zurück zum Zitat Emprechtinger R, Piso B, Ringleb PA (2017) Thrombectomy for ischemic stroke: meta-analyses of recurrent strokes, vasospasms, and subarachnoid hemorrhages. J Neurol 264:432–436CrossRef Emprechtinger R, Piso B, Ringleb PA (2017) Thrombectomy for ischemic stroke: meta-analyses of recurrent strokes, vasospasms, and subarachnoid hemorrhages. J Neurol 264:432–436CrossRef
4.
Zurück zum Zitat Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22:1048–1055CrossRef Abdul-Rahim AH, Fulton RL, Frank B, Tatlisumak T, Paciaroni M, Caso V et al (2015) Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA. Eur J Neurol 22:1048–1055CrossRef
5.
Zurück zum Zitat Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46:2175–2182CrossRef Paciaroni M, Agnelli G, Falocci N, Caso V, Becattini C, Marcheselli S et al (2015) Early recurrence and cerebral bleeding in patients with acute ischemic stroke and atrial fibrillation: effect of anticoagulation and its timing: the RAF study. Stroke 46:2175–2182CrossRef
6.
Zurück zum Zitat Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO et al (2015) Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg 7:16–21CrossRef Nogueira RG, Gupta R, Jovin TG, Levy EI, Liebeskind DS, Zaidat OO et al (2015) Predictors and clinical relevance of hemorrhagic transformation after endovascular therapy for anterior circulation large vessel occlusion strokes: a multicenter retrospective analysis of 1122 patients. J Neurointerv Surg 7:16–21CrossRef
7.
Zurück zum Zitat Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL et al (2013) Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44:2650–2663CrossRef Zaidat OO, Yoo AJ, Khatri P, Tomsick TA, von Kummer R, Saver JL et al (2013) Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke 44:2650–2663CrossRef
8.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef
9.
Zurück zum Zitat Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674CrossRef Barber PA, Demchuk AM, Zhang J, Buchan AM (2000) Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 355:1670–1674CrossRef
10.
Zurück zum Zitat Tei H, Uchiyama S, Usui T, Ohara K (2010) Posterior circulation aspects on diffusion-weighted MRI can be a powerful marker for predicting functional outcome. J Neurol 257:767–773CrossRef Tei H, Uchiyama S, Usui T, Ohara K (2010) Posterior circulation aspects on diffusion-weighted MRI can be a powerful marker for predicting functional outcome. J Neurol 257:767–773CrossRef
11.
Zurück zum Zitat Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E et al (2015) Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in japan: the SAMURAI-NVAF study. Int J Stroke 10:836–842CrossRef Toyoda K, Arihiro S, Todo K, Yamagami H, Kimura K, Furui E et al (2015) Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in japan: the SAMURAI-NVAF study. Int J Stroke 10:836–842CrossRef
12.
Zurück zum Zitat von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD et al (2015) The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46:2981–2986CrossRef von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD et al (2015) The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke 46:2981–2986CrossRef
13.
Zurück zum Zitat Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329CrossRef Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317–1329CrossRef
14.
Zurück zum Zitat Strobl C, Boulesteix A-L, Kneib T, Augustin T, Zeileis A (2008) Conditional variable importance for random forests. BMC Bioinformatics 9:307CrossRef Strobl C, Boulesteix A-L, Kneib T, Augustin T, Zeileis A (2008) Conditional variable importance for random forests. BMC Bioinformatics 9:307CrossRef
15.
Zurück zum Zitat Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030CrossRef Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J et al (2015) Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med 372:1019–1030CrossRef
16.
Zurück zum Zitat Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306CrossRef Jovin TG, Chamorro A, Cobo E, de Miquel MA, Molina CA, Rovira A et al (2015) Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med 372:2296–2306CrossRef
17.
Zurück zum Zitat Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T et al (2019) Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS ONE 14:e0212354CrossRef Yasaka M, Minematsu K, Toyoda K, Mori E, Hirano T, Hamasaki T et al (2019) Rivaroxaban administration after acute ischemic stroke: the RELAXED study. PLoS ONE 14:e0212354CrossRef
18.
Zurück zum Zitat Koga M (2018) More benefits from endovascular thrombectomy in patients with atrial fibrillation. Circ J 82:2483–2484CrossRef Koga M (2018) More benefits from endovascular thrombectomy in patients with atrial fibrillation. Circ J 82:2483–2484CrossRef
19.
Zurück zum Zitat Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W et al (2015) Updated european heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467–1507CrossRef Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W et al (2015) Updated european heart rhythm association practical guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467–1507CrossRef
20.
Zurück zum Zitat Seiffge DJ, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M et al (2019) Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 85:823–834CrossRef Seiffge DJ, Paciaroni M, Wilson D, Koga M, Macha K, Cappellari M et al (2019) Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation. Ann Neurol 85:823–834CrossRef
21.
Zurück zum Zitat Murthy SB, Diaz I, Wu X, Merkler AE, Iadecola C, Safford MM et al (2020) Risk of arterial ischemic events after intracerebral hemorrhage. Stroke 51:137–142CrossRef Murthy SB, Diaz I, Wu X, Merkler AE, Iadecola C, Safford MM et al (2020) Risk of arterial ischemic events after intracerebral hemorrhage. Stroke 51:137–142CrossRef
22.
Zurück zum Zitat Boisseau W, Fahed R, Lapergue B, Desilles JP, Zuber K, Khoury N et al (2019) Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study. Stroke 50:2364–2370CrossRef Boisseau W, Fahed R, Lapergue B, Desilles JP, Zuber K, Khoury N et al (2019) Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study. Stroke 50:2364–2370CrossRef
23.
Zurück zum Zitat Lee YB, Yoon W, Lee YY, Kim SK, Baek BH, Kim JT et al (2019) Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions. J Neurointerv Surg 11:469–473CrossRef Lee YB, Yoon W, Lee YY, Kim SK, Baek BH, Kim JT et al (2019) Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions. J Neurointerv Surg 11:469–473CrossRef
24.
Zurück zum Zitat Ducroux C, Piotin M, Gory B, Labreuche J, Blanc R, Ben Maacha M et al (2020) First pass effect with contact aspiration and stent retrievers in the aspiration versus stentretriever (ASTER) trial. J Neurointerv Surg 12:386–391CrossRef Ducroux C, Piotin M, Gory B, Labreuche J, Blanc R, Ben Maacha M et al (2020) First pass effect with contact aspiration and stent retrievers in the aspiration versus stentretriever (ASTER) trial. J Neurointerv Surg 12:386–391CrossRef
Metadaten
Titel
Early recurrent ischemic events after mechanical thrombectomy: effect of post-treatment intracranial hemorrhage
verfasst von
Junpei Koge
Kanta Tanaka
Takeshi Yoshimoto
Masayuki Shiozawa
Hiroshi Yamagami
Tetsu Satow
Jun C. Takahashi
Masafumi Ihara
Masatoshi Koga
Jun-ichi Kira
Kazunori Toyoda
Publikationsdatum
16.02.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 8/2021
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-021-10449-1

Weitere Artikel der Ausgabe 8/2021

Journal of Neurology 8/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.